To date, IntegraGen has focused its efforts in three areas Metabolic Disease, CNS Disorders, and Cardiac Disease. As IntegraGen moves from discovery towards commercialization within a target disorder, such as Autism, it is our experience that a portfolio of commercialized offering will ensue as well as a broadening of interest and investment in the specific disorder.
IntegraGen, in conjunction with First Signs, Inc. and Boston University School of Medicine, to sponsor CME accredited program at AAP National Conference Satellite Symposia : Autism Spectrum Disorders: Tools to Manage Expectations and Outcomes (AAP National Conference in Boston - Sunday evening - Octobre 12, 2008)
=> more
IntegraGen to exhibit at American Academy of Pediatrics's (AAP) 2008 National Conference in Boston, MA - October 11-14, 2008 - visit us at booth 3772.
> more